Biosimilar Clone Development Service

Biosimilar Clone Development Service
Product Description

At GeNext Genomics, we specialize in end-to-end clone development for biosimilars, catering to the high demand for biologics. Utilizing advanced cell lines such as CHO GS, Expi CHO, HEK, and CHO S, we ensure high-yield, high-quality biosimilar production. Our approach includes detailed characterization and strict alignment with CQAs from innovator molecules to meet regulatory standards. Through a robust, scalable process—from gene synthesis to cell line development and analytical validation—we support our partners in achieving cost-effective, market-ready biosimilars.

GENEXT GENOMICS PVT LTD

  • IN
  • 2024
    On CPHI since
  • 1
    Certificates
  • 1 - 24
    Employees
Company types
Biopharmaceutical company
Contract Research Organisation (CRO)
Generics/Biosimilars Manufacturer
Primary activities
Analytical Services
Biopharmaceutical
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Specifications
  • Details
    At GeNext Genomics, we specialize in end-to-end clone development for biosimilars, catering to the high demand for biologics. Utilizing advanced cell lines such as CHO GS, Expi CHO, HEK, and CHO S, we ensure high-yield, high-quality biosimilar production. Our approach includes detailed characterization and strict alignment with CQAs from innovator molecules to meet regulatory standards. Through a robust, scalable process—from gene synthesis to cell line development and analytical validation—we support our partners in achieving cost-effective, market-ready biosimilars.
  • Supplied from
    India
  • Measured In
    milligram

GENEXT GENOMICS PVT LTD

  • IN
  • 2024
    On CPHI since
  • 1
    Certificates
  • 1 - 24
    Employees
Company types
Biopharmaceutical company
Contract Research Organisation (CRO)
Generics/Biosimilars Manufacturer
Primary activities
Analytical Services
Biopharmaceutical
Contract Research Organisation
Custom Manufacturing/Custom Synthesis

More Products from GENEXT GENOMICS PVT LTD (1)

  • Golimumab

    Product Golimumab

    Golimumab is a monoclonal antibody that targets and inhibits tumor necrosis factor-alpha (TNF-α), a cytokine involved in inflammatory responses. By blocking TNF-α, golimumab helps reduce inflammation and is primarily used to treat autoimmune diseases such as:

    • Rheumatoid arthritis (RA) • Psor...